Overview

Cosopt Versus Xalacom

Status:
Completed

Trial end date:
2007-04-01

Target enrollment:

Participant gender:

Summary

To compare the intraocular pressure efficacy and safety of the DTFC given twice daily versus the LTFC given once every morning following a run-in period with timolol maleate given twice daily.

Phase:

Phase 4

Details

Lead Sponsor:

Pharmaceutical Research Network

Treatments:

Dorzolamide
Latanoprost
Maleic acid
Timolol